UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Advances in language and literary studies, ISSN 2203-4714, 02/2019, Volume 10, Issue 1, pp. 9 - 16
Journal Article
Therapeutic advances in respiratory disease, ISSN 1753-4666, 6/2016, Volume 10, Issue 3, pp. 183 - 193
pembrolizumab | nivolumab | NSCLC | pneumonitis | ipilimumab | Life Sciences & Biomedicine | Respiratory System | Science & Technology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Ipilimumab | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Risk | Antineoplastic Agents - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Pneumonia - chemically induced | Antineoplastic Agents - pharmacology | Neoplasms - pathology | Cancer | Index Medicus | Original Research
Journal Article
Future oncology (London, England), ISSN 1479-6694, 02/2016, Volume 12, Issue 3, pp. 413 - 425
adrenal insufficiency | nivolumab | hypothyroidism | ipilimumab | Life Sciences & Biomedicine | Oncology | Science & Technology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Endocrine System Diseases - chemically induced | Humans | Ipilimumab | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Risk | Antineoplastic Agents - therapeutic use | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Antineoplastic Agents - adverse effects | Neoplasms - immunology
Journal Article
Critical reviews in oncology/hematology, ISSN 1040-8428, 2013, Volume 91, Issue 1, pp. 1 - 8
Hematology, Oncology and Palliative Medicine | Hepatocellular carcinoma | Chemotherapy | Combined treatment | Sorafenib | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Niacinamide - analogs & derivatives | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Carcinoma, Hepatocellular - drug therapy | Phenylurea Compounds - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Liver Neoplasms - drug therapy | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Niacinamide - administration & dosage | Antimitotic agents | Care and treatment | Mortality | Hepatoma | Drug therapy | Antineoplastic agents | Cancer | Index Medicus
Journal Article
Critical reviews in oncology/hematology, ISSN 1040-8428, 2014, Volume 92, Issue 3, pp. 194 - 207
Hematology, Oncology and Palliative Medicine | Hypertension | Left ventricular dysfunction | Sunitinib | Cardiovascular toxicities | Meta-analysis | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Humans | Risk | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Incidence | Neoplasms - complications | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Angiogenesis Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Pyrroles - adverse effects | Imidazoles - therapeutic use | Pyrroles - therapeutic use | Angiogenesis Inhibitors - adverse effects | Cardiovascular Diseases - diagnosis | Pyridines - therapeutic use | Cardiovascular Diseases - etiology | Imidazoles - adverse effects | Phenylurea Compounds - therapeutic use | Neoplasms - drug therapy | Indoles - adverse effects | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Indoles - therapeutic use | Indazoles - adverse effects | Indazoles - therapeutic use | Antimitotic agents | Care and treatment | Cardiac patients | Comparative analysis | Antineoplastic agents | Risk factors | Tumors | Index Medicus
Journal Article
Pharmaceutical biology, ISSN 1388-0209, 01/2017, Volume 55, Issue 1, pp. 758 - 765
diaphragm | insulin resistance | Diabetes | Insulin resistance | Diaphragm | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Plant Sciences | Medical Laboratory Technology | Science & Technology | Diabetes Mellitus, Experimental - drug therapy | Plant Extracts - pharmacology | Streptozocin | Momordica charantia | Pancreas - pathology | Rats | Male | Antioxidants - pharmacology | Pancreas - metabolism | Hypoglycemic Agents - pharmacology | Animals | Diabetes Mellitus, Experimental - pathology | Fruit and Vegetable Juices | Prophylaxis | Oral administration | Muscles | Triglycerides | Glucose | Insulin | Malondialdehyde | Cholesterol | Beta cells | Antioxidants | Rodents | Pancreas | Diabetes mellitus (non-insulin dependent) | Lipoproteins (high density) | Glutathione | Fruit juices | Index Medicus | diabetes
Journal Article
Critical reviews in oncology/hematology, ISSN 1040-8428, 2014, Volume 93, Issue 2, pp. 127 - 135
Hematology, Oncology and Palliative Medicine | Cetuximab | Skin rash | Meta-analysis | Exanthema - diagnosis | Receptor, Epidermal Growth Factor - genetics | Prognosis | Carcinoma, Squamous Cell - pathology | Humans | Carcinoma, Non-Small-Cell Lung - diagnosis | Colorectal Neoplasms - diagnosis | Carcinoma, Squamous Cell - diagnosis | Carcinoma, Squamous Cell - mortality | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Colorectal Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - pathology | Colorectal Neoplasms - mortality | Severity of Illness Index | Antibodies, Monoclonal, Humanized - adverse effects | Gene Expression | Head and Neck Neoplasms - drug therapy | Treatment Outcome | Clinical Trials as Topic | Carcinoma, Non-Small-Cell Lung - mortality | Head and Neck Neoplasms - pathology | Carcinoma, Squamous Cell - drug therapy | Exanthema - pathology | Survival Analysis | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Head and Neck Neoplasms - diagnosis | Carcinoma, Non-Small-Cell Lung - drug therapy | Head and Neck Neoplasms - mortality | Colorectal Neoplasms - pathology | Antimitotic agents | Care and treatment | Patient outcomes | Analysis | Rash (Dermatology) | Skin | Antineoplastic agents | Tumors | Index Medicus
Journal Article
Prenatal diagnosis, ISSN 0197-3851, 12/2020, Volume 40, Issue 12, pp. 1578 - 1597
Genetics & Heredity | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Pregnant women | Ultrasound imaging | Analysis | Calcification | Diagnostic imaging | Nucleotide sequencing | DNA sequencing | Hypoplasia | Cerebellum | Calcification (ectopic) | Phenotypes | Nonsense mutation | Fetuses | Feature recognition | Aquatic plants | Corpus callosum | Biomedical materials | Ultrasonic imaging | Prenatal diagnosis | Fractures | Morphology | Diagnosis | Ventricle | Mutation | Ultrasound | Index Medicus
Journal Article
Journal of cancer research and clinical oncology, ISSN 0171-5216, 2/2015, Volume 141, Issue 2, pp. 295 - 305
Neuroendocrine neoplasms | Chemotherapy | Medicine & Public Health | Hematology | Oncology | Cancer Research | Internal Medicine | Combined treatment | Bevacizumab | Life Sciences & Biomedicine | Science & Technology | Pancreatic Neoplasms - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Prognosis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Angiogenesis Inhibitors - therapeutic use | Neuroendocrine Tumors - drug therapy | Clinical Trials as Topic | Stomach Neoplasms - drug therapy | Intestinal Neoplasms - drug therapy | Care and treatment | Angiogenesis inhibitors | Tumors | Index Medicus
Journal Article
Future oncology (London, England), ISSN 1479-6694, 09/2015, Volume 11, Issue 17, pp. 2471 - 2484
pruritus | vitiligo | rash | nivolumab | ipilimumab | Life Sciences & Biomedicine | Oncology | Science & Technology | Molecular Targeted Therapy - adverse effects | Humans | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Risk | Antineoplastic Agents - therapeutic use | Incidence | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Skin Diseases - etiology | Neoplasms - complications | Antineoplastic Agents - adverse effects | Skin Diseases - epidemiology | Odds Ratio | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2012, Volume 366, Issue 25, pp. 2345 - 2357
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Biological and medical sciences | Medical sciences | Epidemiology | Tumors | Colorectal Neoplasms - epidemiology | Colorectal Neoplasms - mortality | Early Detection of Cancer | Humans | Middle Aged | Colorectal Neoplasms - prevention & control | Male | Equipment Contamination | Colorectal Neoplasms - diagnosis | Incidence | Sigmoidoscopes | Sigmoidoscopy - instrumentation | Female | Aged | Neoplasm Staging | Usage | Sigmoidoscopy | Colorectal cancer | Diagnosis | Medical screening | Risk factors | Methods | Colorectal carcinoma | Mortality | Questionnaires | Index Medicus | Abridged Index Medicus
Journal Article